Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma

NCT00301418 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme
Anaplastic Astrocytoma

Interventions

DRUG: Erlotinib

Sponsor

Northwell Health

Collaborators

[object Object]